Oct 8, 2024 Gastro Broadcast Independent GI Radio: Episode #65: Identifying High-Risk Barrett’s Esophagus Patients
Oct 1, 2024 Gastroenterology & Hepatology: Nonendoscopic Testing for Esophageal Precancer in an At-Risk Population
Sep 30, 2024 The Dermatology Digest: Castle Biosciences, Inc.’s DecisionDx-SCC Better IDs High-risk Immune-suppressed SCC Patients Who Need ART
Sep 16, 2024 TechBullion: Castle Biosciences’ COO Kristen Oelschlager Honoured as Arizona Bioscience Leader of the Year
Sep 5, 2024 The Dermatology Digest: Castle’s DecisionDx-SCC Test Predicts Likelihood of Benefit From Adjuvant Radiation Therapy in SCC
Aug 29, 2024 Houston Business Journal: Cancer Diagnostics Co. Castle Biosciences to Build New Headquarters in Friendswood
Aug 27, 2024 American Academy of Ophthamology: An Integrated 15-GEP/PRAME Tool May Improve Uveal Melanoma Prognostication
